Prime examples are the use of tumor-specific promoters such as carcinoembryonic antigen (CEA), telomerase reverse transcriptase (TERT) or Survivin promoters, which are active in cancer cells, but silent in differentiated healthy cells [40,41]. The gene discussed is TERT; the disease is neoplasm.